Adverse events associated with mood stabiliser treatment should be continuously monitored in patients diagnosed with bipolar affective disorder
Evid Based Med
.
2017 Apr;22(2):74-75.
doi: 10.1136/ebmed-2016-110629.
Epub 2017 Mar 2.
Authors
R E Nielsen
1
2
,
R W Licht
3
Affiliations
1
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
2
Department of Psychiatry, Unit for Psychiatric Research, Aalborg University Hospital, Aalborg, Denmark.
3
Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark.
PMID:
28254753
DOI:
10.1136/ebmed-2016-110629
No abstract available
Publication types
Comment
MeSH terms
Antimanic Agents*
Bipolar Disorder*
Humans
Monitoring, Physiologic
Mood Disorders
Substances
Antimanic Agents